CLOs on the Move

Surgery Partners

www.surgerypartners.com

 
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Spencer Clark
SVP and General Counsel Profile
Roxanne Womack
SVP, Chief Compliance Officer Profile
Spencer Clark
VP and Senior Legal Counsel Profile
Kelly Whelan
VP and Senior Legal Counsel, American and Eastern Groups Profile

Similar Companies

Vista Oaks of Lakeway Assisted

Vista Oaks of Lakeway Assisted is a Austin, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Mid South Health System

Mid South Health System is a Jonesboro, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ICS Connect

ICS Connect is a Frisco, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WellGen

WellGen is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in N Brunswick, NJ. To find more information about WellGen, please visit www.amphioncap.com

Relievant Medsystems

Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous Nerve Ablation System leverages proprietary instruments and methods to disable this nerve.